Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21)

Saved in:
Bibliographic Details
Published in:Annals of hematology 2017-12, Vol.96 (12), p.2127-2129
Main Authors: Shao, Haigang, Yang, Qian, Wu, Chunxiao, Cen, Jiannong, Chen, Suning, Pan, Jinlan
Format: Article
Language:English
Subjects:
Adolescent
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
CCAAT-Binding Factor - genetics
Chromosome Inversion
Chromosomes, Human, Pair 16 - ultrastructure
Chromosomes, Human, Pair 21 - ultrastructure
Chromosomes, Human, Pair 8 - ultrastructure
Combined Modality Therapy
Core Binding Factor Alpha 2 Subunit - genetics
Cytarabine - administration & dosage
Cytarabine - adverse effects
Female
Hematology
Humans
Idarubicin - administration & dosage
Idarubicin - adverse effects
In Situ Hybridization, Fluorescence
Letter to the Editor
Leukemia, Myeloid, Acute - chemically induced
Leukemia, Myeloid, Acute - drug therapy
Leukemia, Myeloid, Acute - genetics
Leukemia, Myeloid, Acute - therapy
Medicine
Medicine & Public Health
Myosin Heavy Chains - genetics
Neoplasms, Second Primary - chemically induced
Neoplasms, Second Primary - genetics
Oncogene Proteins, Fusion - genetics
Oncology
Peripheral Blood Stem Cell Transplantation
Reverse Transcriptase Polymerase Chain Reaction
RUNX1 Translocation Partner 1 Protein - genetics
Translocation, Genetic
Transplantation, Autologous
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0939-5555
1432-0584
DOI:10.1007/s00277-017-3110-y